TNF blocker safety may differ in RA and psoriasis patients

Rheumatoid arthritis patients on anti–tumor necrosis factor medications had approximately twice the rate of serious adverse events as did psoriasis patients on the same medications, based on data from a pair of prospective studies of about 4,000 adults. The findings were published online in the...
Source: Skin and Allergy News - Category: Dermatology Source Type: news